Literature DB >> 8763338

Major vault protein LRP-related multidrug resistance.

M A Izquierdo1, G L Scheffer, M J Flens, A B Schroeijers, P van der Valk, R J Scheper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8763338     DOI： 10.1016/0959-8049(96)00053-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  12 in total

1.  Expression of lung resistance protein in patients with gastric carcinoma and its clinical significance.

Authors:  Zhong-Min Liu; Nan-Hai Shou; Xi-Hong Jiang
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Vault-related resistance to anticancer drugs determined by the expression of the major vault protein LRP.

Authors:  M A Izquierdo; G L Scheffer; A B Schroeijers; M C de Jong; R J Scheper
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 3.  Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy.

Authors:  Ana Carolina Rabello de Moraes; Caroline Klein Maranho; Gabriela Schneider Rauber; Maria Cláudia Santos-Silva
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

4.  Major vault protein of electric ray is a phosphoprotein.

Authors:  C Herrmann; R Kellner; W Volknandt
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

Review 5.  Classical multidrug resistance in acute myeloid leukaemia.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

6.  Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.

Authors:  Florian Hohla; Andrew V Schally; Celia A Kanashiro; Stefan Buchholz; Benjamin Baker; Chandrika Kannadka; Angelika Moder; Elmar Aigner; Christian Datz; Gabor Halmos
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

7.  Topoisomerase I inhibitors and drug resistance.

Authors:  R E Parchment; A Pessina
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression.

Authors:  J Beck; B Bohnet; D Brügger; P Bader; J Dietl; R J Scheper; R Kandolf; C Liu; D Niethammer; V Gekeler
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.

Authors:  E Dolfini; T Dasdia; G Arancia; A Molinari; A Calcabrini; R J Scheper; M J Flens; M B Gariboldi; E Monti
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 10.  Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Authors:  Maurice Zandvliet; Erik Teske
Journal:  Vet Sci       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.